Effectiveness of Vitamin C Administration on Outcome in COVID-19 Patients: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.36497/jri.v43i2.341Keywords:
ascorbic acid, mortality, SARS-CoV-2, supplementsAbstract
Background: Numerous studies on the effectiveness of vitamin C against the COVID-19 infection have been widely carried out recently. However, the differences in dosage ranges and therapeutic efficacy in previous studies have prompted a systematic literature review on the effectiveness of vitamin C on outcomes in COVID-19 patients. In addition, this study aimed to determine the appropriate therapeutic dose of vitamin C for COVID-19 patients, either alone or in combination with other supplements, and to determine the side effects.
Methods: Gleaned from the search on Pubmed, Science Direct, and Google Scholar databases up to April 25, 2022, fourteen studies were relevant, namely five studies using vitamin C orally and nine studies administered intravenously. We assessed multiple outcomes, including mortality, hospitalization, and symptoms. The quality and risk of bias analyses were performed using JBI critical appraisal tools.
Results: The oral administration of vitamin C resulted in a significant difference in the mortality of COVID-19 patients (OR=0.66; 95% CI=0.45–0.97; P=0.04; I2=0%) and a non-significant difference in the outcome. Duration of hospitalization (OR = -0.21; 95% CI = -2.70-2.28; P=0.87; I2=94%). Regarding the cost-effectiveness and side effects manifested in digestive disorders such as nausea, diarrhea, stomach cramps, and vomiting, vitamin C with a dose of 500-1000 mg could be given orally.
Conclusion: Oral administration of vitamin C showed a reduction in the mortality of asymptomatic COVID-19 patients with moderate symptoms.
Downloads
References
WHO. Coronavirus [Homepage on the Internet]. 2021 [cited 2021 Sep 14];19–22. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1
Kemenkes. Protokol Tatalaksana Covid-19 [Homepage on the Internet]. Buku Saku. Jakarta: Kementerian Kesehatan RI, 2021; Available from: https://promkes.kemkes.go.id/buku-saku-protokol-tata-laksana-covid-19
Kumari P, Dembra S, Dembra P, et al. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus 2020;12(11):10–13.
Mrityunjaya M, Pavithra V, Neelam R, Janhavi P, Halami PM, Ravindra P V. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Front Immunol 2020;11:1–12.
Bauer SR, Kapoor A, Rath M, Thomas SA. What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N -acetylcysteine for prevention or treatment of COVID-19? . Cleve Clin J Med 2020;3–5.
Beltrán-García J, Osca-Verdegal R, Pallardó F V., et al. Oxidative stress and inflammation in covid-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants 2020;9(10):1–20.
Fantacone ML, Lowry MB, Uesugi SL, et al. The effect of a multivitamin and mineral supplement on immune function in healthy older adults: A double-blind, randomized, controlled trial. Nutrients 2020;12(8):1–15.
Pirabbasi E, Shahar S, Manaf ZA, Rajab NF, Manap RA. Efficacy of ascorbic acid (Vitamin C) and/N-acetylcysteine (NAC) supplementation on nutritional and antioxidant status of male chronic obstructive pulmonary disease (COPD) patients. J Nutr Sci Vitaminol (Tokyo) 2016;62(1):54–61.
Lee SI, Lim CM, Koh Y, Huh JW, Lee JS, Hong SB. The effectiveness of vitamin C for patients with severe viral pneumonia in respiratory failure. J Thorac Dis 2021;13(2):632–641.
JamaliMoghadamSiahkali S, Zarezade B, Koolaji S, et al. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res. 2021;26(1):1–9.
Kumari P, Dembra S, Dembra P, et al. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus 2020;12(11):10–13.
Gao D, Xu M, Wang G, et al. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging (Albany NY) 2021;13(5):7020–7034.
Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020;10(7):e039519.
Sulaiman K Al, Aljuhani O, Saleh K Bin, et al. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Sci Rep. 2021;11(1):1–8.
Suna K. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia. Med Clin (Barc). 2022;158(8):356–360.
Zhang J, Rao X, Li Y, et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):3–14.
Zheng S, Chen Q, Jiang H, Guo C, Luo J, Li S. No signi fi cant bene fi t of moderate - dose vitamin C on severe COVID - 19 cases. 2021;1403–1414.
Li M, Ching TH, Hipple C, Lopez R, Sahibzada A, Rahman H. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection. J Pharm Pract 2021;1–7.
Majidi N, Rabbani F, Gholami S, et al. The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial. Front Immunol. 2021;12:717816.
Hakamifard A, Soltani R, Maghsoudi A, et al. The effect of Vitamin E and Vitamin C on quality of life in patients with type 2 diabetes: A single-blind randomized clinical trial. Jundishapur J Nat Pharm Prod 2021;14(4):1–6.
Thomas S, Patel D, Bittel B, et al. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw open 2021;4(2):e210369.
Ried K, BinJemain T, Sali A. Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial. Cureus 2021;13(11).
Margolin L, Luchins J, Margolin D, Margolin M, Lefkowitz S. 20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment. J evidence-based Integr Med. 2021;26:2515690X211026193.
Enst WA Van, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. Investigation of publication bias in meta-analyses of diagnostic test accuracy: A meta-epidemiological study. BMC Med Res Methodol 2014;14(1):1–11.
Rawat D, Roy A, Maitra S, Gulati A, Khanna P, Baidya DK. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr Clin Res Rev. 2021;15(6):102324.
Beran A, Mhanna M, Srour O, et al. Clinical significance of micronutrient supplements in patients with coronavirus disease 2019: A comprehensive systematic review and meta-analysis. Clin Nutr ESPEN. 2022;48:167–177.
Rawat D, Roy A, Maitra S, Gulati A, Khanna P, Baidya DK. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr Clin Res Rev. 2021;15(6):102324.
Kumari P, Dembra S, Dembra P, et al. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus 2020;12(11):10–13.
Arifah IF, Novitasari D, Permatasari PS, Naomi EFF. Pengetahuan Tentang Injeksi Vitamin C Untuk Di Kalangan Mahasiswi Kampus B Universitas. J Farm Komunitas 2018;5(1):18–24.
Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res 2020;226:57–69.
Fowler AA, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12(1):1–10.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
